Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The announcement by US ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

The trial, published Feb. 4 in The Lancet, followed 194 people with Parkinson's disease for 96 weeks. Patients were randomly assigned to inject either Byetta or a placebo once a week. The results?

Lung cancer is the commonest form of the disease, with 2.5 million people diagnosed in 2022, said the study, published in the Lancet Respiratory Medicine journal on World Cancer Day.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox. From our morning news briefing to a weekly Good News Newsletter, get the ...